Addpharma Inc.

25 Tapsil-ro 35beon-gil, Giheung-gu, Yongin, Gyeonggi, South Korea

Clinical Trials

18 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

72.4%

Phase 3

22.4%

Phase 2

5.2%

Trial Status Distribution

Completed

56.9%

Not yet recruiting

31.0%

Recruiting

12.1%

Clinical Trials

Trials sponsored by this organization (58)

A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy

Phase 3

Not yet recruiting

interventional

Sep 2026354 participants

A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults

Phase 1

Not yet recruiting

interventional

Aug 202630 participants

A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

Phase 1

Not yet recruiting

interventional

Jul 202644 participants

A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Phase 1

Not yet recruiting

interventional

Jul 202674 participants

A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

Phase 1

Not yet recruiting

interventional

Jul 202644 participants

A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Phase 1

Not yet recruiting

interventional

Jul 202644 participants

A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

Phase 1

Not yet recruiting

interventional

Jun 202660 participants

Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee

Phase 2

Not yet recruiting

interventional

Jun 2026200 participants

Page 1 of 8

Approvals

No approval data available

News

No news articles found

Back to Organizations